Anti-inflammatory-drug-induced pharmacodermia
DOI:
https://doi.org/10.46551/ruc.v27n2a4Keywords:
Drug eruptions, Dermatitis medicamentosa, Adverse Drug EventAbstract
Objective: to report a case of pharmacodermy treated at Clemente de Faria Hospital, and to discuss the diagnostic and therapeutic methods employed. Method: a descriptive observational case-report study, carried out through analysis of health records. Discussion: the distribution of bullous lesions on the back of the neck, upper trunk and hands, in addition to intense eosinophilia, accompanied by increased C-reactive protein and liver enzymes, made the patient's condition similar to Drug-induced hypersensitivity syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome (DIHS/DRESS). Final considerations: pharmacodermy are rare and potentially fatal. Case reports allow the construction of clinical reasoning that, associated with laboratory parameters, improve the quality of care and allow early identification of reactions.
Downloads
References
PARK, Chan Sun et al. Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea. Allergy, Asthma & Immunology Research. 2019; 11(5): 709.
MELO, Maria Eduarda Fernandes de et al.. Principais classes farmacológicas relacionadas à farmacodermia. Research, Society and Development. 2022 Jan 18;11(2):e8011225492.
FIGUEIREDO, Izabela Rodrigues et al. Pharmacodermia induced by Bupropion in a patient with major depression disorder. Rev Med Saude Brasilia 2017; 6(3): 334-340.
BULISANI, Ana Carolina Pedigoni et al. Síndrome de Stevens-Johnson e necrólise epidérmica tóxica em medicina intensiva. Revista Brasileira de Terapia Intensiva. 2006 Sep;18(3):292–7.
CASAL-BELOY, Isabel et al. Dress syndrome, a differencial diagnosis in late postoperative complications. Anales del Sistema Sanitario de Navarra. 2019; 42(1): 89–92.
GIBSON, Andrew et al. Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. Journal of Allergy and Clinical Immunology. Vol. 151, Elsevier Inc.; 2023. p. 289-300.e4.
CHO Yung-Tsu; YANG, Che-Wen; CHU Chia Yu. Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system. International Journal of Molecular Sciences. 2017 Jun 9;18(6).
BRÜGGEN, Marie-Charlotte et al. Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms. JAMA Dermatology. 2024 Jan 1;160(1):37.
TSAI, Tsung-Yu et al. Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis. Journal of the American Academy of Dermatology. 2021 Feb 1;84(2):390–7.
WANG, Sifan et al. The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids. World Allergy Organization Journal. 2024 Aug;17(8):100935.
